Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Experts evaluate new consensus recommendations involving rare cancer on CT

Researchers referred to the newly developed Korean Society of Abdominal Radiology consensus recommendations when evaluating the CT scans of patients with extrahepatic bile duct cancer.

Algorithm performs at expert level when distinguishing between benign and malignant ovarian tumors

Experts involved with the study suggested that these findings could be beneficial in the future of ovarian tumor assessment by providing clinical decision making support.

Pre-treatment chest CT features can predict overall survival in lung cancer patients

The noncancerous imaging features obtained before radiation therapy could be used in the future to help guide treatment decisions for these patients, experts suggested.

DBT-based radiomics nomogram predicts lymphovascular invasion in breast cancer patients

The DBT-based combined radiomic nomogram achieved a specificity of nearly 95% when predicting lymphovascular invasion, which was higher than other clinical predictive models.

Combination therapy that includes new radionuclide proves effective for metastatic prostate cancer

The therapeutic combination of 177Lu-PSMA-617 with idronoxil (NOX66) reduced PSA levels in 86% of study participants.

'Surprising' decline in annual screening among breast cancer survivors has experts concerned

The downward trend in annual mammography adherence should serve as a call to action for new processes to engage breast cancer survivors, physicians urged.

Men treated for prostate cancer have increased fracture risk, yet few complete DXA screening

Out of 50,000 men included in the study, 17.5% sustained a fracture after beginning prostate cancer treatment, but only 7.9% received such scans.

A new mobile prostate cancer screening unit has just been launched by Mount Sinai Health in New York City.

Mobile prostate cancer screening unit hits the streets of NYC

The Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit was developed with the intention of increasing access to screening and supporting prostate health in the Black community.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care